Demographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: A real-life study

dc.contributor.authorSuerdem, Mecit
dc.contributor.authorGünen, Hakan
dc.contributor.authorAkyıldız, Levent
dc.contributor.authorÇilli, Aykut
dc.contributor.authorÖzlü, Tevfik
dc.contributor.authorAbadoğlu, Öznur
dc.contributor.authorBayram, Hasan
dc.contributor.authorCimrin, Arif Hikmet
dc.contributor.authorGemicioğlu, Bilun
dc.contributor.authorMısırlıgil, Zeynep
dc.contributor.buuauthorUzaslan, Esra
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Göğüs Hastalıkları Bölümütr_TR
dc.contributor.researcheridAAI-1004-2021tr_TR
dc.contributor.scopusid8761653500tr_TR
dc.date.accessioned2024-01-29T12:38:26Z
dc.date.available2024-01-29T12:38:26Z
dc.date.issued2020
dc.description.abstractPurpose: In order to determine the clinical and sociodemographic characteristics of newly diagnosed treatment-naïve asthma and COPD patients in Turkey, a multicenter study in 2012 was initiated . We aimed to investigate the characteristics and therapies of COPD patients in the original study in more detail. Patients and Methods: This nation-wide, multicentric, non-interventional, prospective, real-life observational cohort study was conducted in 122 centers. The newly diagnosed patients were not receiving any treatment before the recruitment. Their general characteristics, the combined GOLD 2011 COPD categories and exacerbation histories were noted. The patients were followed up with 3 voluntary visits for 1 year. Their adherence to the inhaled treatment according to GOLD 2011 was evaluated during follow-up visits. Results: The study included 776 COPD patients. Their mean age was 59.4±9.1 years, and 11.9% of the patients were female. 35.1% of the patients were in the GOLD 2011 C and D category. 12.6% are frequent exacerbators, and 52.8% had at least one comorbid condition. 71.8% overtreatment rate was detected. Their attendance rates for three follow-up visits became 55.9%, 32.9% and 18.7%, respectively. The adherence rate to the treatment was measured as 81.9%. Conclusion: Although these patients were diagnosed for the first time, the GOLD C and D categories and frequent exacerbator phenotype were found at a high rate. They were usually prescribed an overtreatment regimen. We think that newly diagnosed COPD patients should be evaluated carefully, and best effort should be made to treat these patients in accordance with the recommendations of the major COPD guidelines.en_US
dc.description.sponsorshipAbdi Ibrahim Ilac San. ve Tic. AS, Turkeytr_TR
dc.description.sponsorshipAbdi Ibrahimtr_TR
dc.description.sponsorshipSanofitr_TR
dc.description.sponsorshipAstraZenecatr_TR
dc.description.sponsorshipNovartistr_TR
dc.description.sponsorshipDevatr_TR
dc.identifier.citationUzunaslan, E. vd. (2020). ''Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study''. International Journal of Chronic Obstuctive Pulmonary Disease, 15, 261-267.en_US
dc.identifier.doihttps://doi.org/10.2147/COPD.S211838
dc.identifier.endpage267tr_TR
dc.identifier.issn1178-2005
dc.identifier.pubmed32103925tr_TR
dc.identifier.scopus2-s2.0-85079468793tr_TR
dc.identifier.startpage261tr_TR
dc.identifier.urihttps://www.dovepress.com/demographic-clinical-and-management-characteristics-of-newly-diagnosed-peer-reviewed-fulltext-article-COPDtr_TR
dc.identifier.urihttps://hdl.handle.net/11452/39369
dc.identifier.volume15tr_TR
dc.identifier.wos000515242300001tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherDove Medical Press Ltd.en_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalInternational Journal of Chronic Obstuctive Pulmonary Diseaseen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOPDen_US
dc.subjectNewly diagnoseden_US
dc.subjectTreatment naiveen_US
dc.subjectExacerbationsen_US
dc.subjectObstructive pulmonary-diseaseen_US
dc.subjectHealt-statusen_US
dc.subjectAsthmaen_US
dc.subjectComorbiditiesen_US
dc.subjectPrevalenceen_US
dc.subjectSpirometryen_US
dc.subjectCountriesen_US
dc.subjectOutcomesen_US
dc.subject.emtreeBeta adrenergic receptor stimulating agenten_US
dc.subject.emtreeCorticosteroiden_US
dc.subject.emtreeLong acting drugen_US
dc.subject.emtreeMuscarinic receptor blocking agenten_US
dc.subject.emtreeRespiratory tract agenten_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeChronic obstructive lung diseaseen_US
dc.subject.emtreeCohort analysisen_US
dc.subject.emtreeComorbidityen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDisease exacerbationen_US
dc.subject.emtreeDisease severityen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMedication complianceen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeObservational studyen_US
dc.subject.emtreePatient attendanceen_US
dc.subject.emtreePatient complianceen_US
dc.subject.emtreePrescriptionen_US
dc.subject.emtreeProspective studyen_US
dc.subject.emtreeTurkey (republic)en_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeChronic obstructive lung diseaseen_US
dc.subject.emtreeClinical practiceen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeDrug utilizationen_US
dc.subject.emtreeMedication overuseen_US
dc.subject.emtreeMulticenter studyen_US
dc.subject.emtreePathophysiologyen_US
dc.subject.emtreePractice guidelineen_US
dc.subject.emtreeProtocol complianceen_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.emtreeTurkey (bird)en_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshComorbidityen_US
dc.subject.meshDisease progressionen_US
dc.subject.meshDrug utilizationen_US
dc.subject.meshFemaleen_US
dc.subject.meshGuideline adherenceen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMedication adherenceen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshPractice guidelines as topicen_US
dc.subject.meshPractice patternsen_US
dc.subject.meshPhysicians'en_US
dc.subject.meshPrescription drug overuseen_US
dc.subject.meshProspective studiesen_US
dc.subject.meshPulmonary diseaseen_US
dc.subject.meshChronic obstructiveen_US
dc.subject.meshRespiratory system agentsen_US
dc.subject.meshTreatment outcomeen_US
dc.subject.meshTurkeyen_US
dc.subject.scopusChronic Obstructive Lung Disease; Spirometry; Primary Careen_US
dc.subject.wosRespiratory systemen_US
dc.titleDemographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: A real-life studyen_US
dc.typeArticleen_US
dc.wos.quartileQ2en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: